Premium
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
Author(s) -
Corey Kathleen E.,
Chalasani Naga
Publication year - 2011
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.24696
Subject(s) - pioglitazone , insulin resistance , nonalcoholic fatty liver disease , metformin , lipotoxicity , medicine , endocrinology , steatohepatitis , steatosis , fatty liver , cirrhosis , lipogenesis , metabolic syndrome , type 2 diabetes , insulin , diabetes mellitus , adipose tissue , disease